Literature DB >> 20877124

A genome-wide association study of hypertension-related phenotypes in a Japanese population.

Yumiko Hiura1, Yasuharu Tabara, Yoshihiro Kokubo, Tomonori Okamura, Tetsuro Miki, Hitonobu Tomoike, Naoharu Iwai.   

Abstract

BACKGROUND: Large-scale genome-wide association studies (GWAS) have been successful in identifying genes that contribute to common diseases and phenotypes. A GWAS of hypertension-related phenotypes in a Japanese population was conducted in the current study. METHODS AND
RESULTS: A total of 936 participants were recruited from the Suita Study and a GWAS with 538,732 single nucleotide polymorphisms (SNP) was performed. The phenotypes included were systolic and diastolic blood pressure (SBP and DBP), body mass index (BMI), waist-to-hip ratio (WHR), plasma renin activity (PRA), plasma aldosterone concentration (PAC), plasma brain natriuretic peptide (BNP) concentration and alcohol consumption (AC). The SNP exceeding the genome-wide significance level were subjected to subsequent association studies using samples available from the Suita Study and Nomura Study. There is no master gene in the Japanese population that profoundly affects SBP, DBP, BMI, WHR, PRA and PAC. AC was influenced by the functional polymorphism in ALDH2, which affected BP levels in men. The BNP concentration was influenced by a polymorphism in the 3' region of the gene encoding for BNP. However, this polymorphism did not influence blood pressure (BP). Six SNP were identified to be associated with hypertension in both the Suita and Nomura studies.
CONCLUSIONS: Although several candidate SNP relevant to hypertension and those influencing AC and BNP were identified, our middle-sized GWAS indicated that there is no master gene in Japanese people that profoundly affects BP-related phenotypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20877124     DOI: 10.1253/circj.cj-10-0353

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  31 in total

Review 1.  Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics.

Authors:  Jacob Basson; Jeannette Simino; D C Rao
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

2.  Refined mapping of blood pressure quantitative trait loci using congenic strains developed from two genetically hypertensive rat models.

Authors:  Sivarajan Kumarasamy; Kathirvel Gopalakrishnan; Edward J Toland; Shane Yerga-Woolwine; Phyllis Farms; Eric E Morgan; Bina Joe
Journal:  Hypertens Res       Date:  2011-08-04       Impact factor: 3.872

3.  Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway.

Authors:  Malapaka Kiranmayi; Venkat R Chirasani; Prasanna K R Allu; Lakshmi Subramanian; Elizabeth E Martelli; Bhavani S Sahu; Durairajpandian Vishnuprabu; Rathnakumar Kumaragurubaran; Saurabh Sharma; Dhanasekaran Bodhini; Madhulika Dixit; Arasambattu K Munirajan; Madhu Khullar; Venkatesan Radha; Viswanathan Mohan; Ajit S Mullasari; Sathyamangla V Naga Prasad; Sanjib Senapati; Nitish R Mahapatra
Journal:  Hypertension       Date:  2016-06-20       Impact factor: 10.190

Review 4.  Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.

Authors:  Che-Hong Chen; Julio Cesar Batista Ferreira; Eric R Gross; Daria Mochly-Rosen
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

5.  Burden of risk alleles for hypertension increases risk of intracerebral hemorrhage.

Authors:  Guido J Falcone; Alessandro Biffi; William J Devan; Jeremiasz M Jagiella; Helena Schmidt; Brett Kissela; Björn M Hansen; Jordi Jimenez-Conde; Eva Giralt-Steinhauer; Roberto Elosua; Elisa Cuadrado-Godia; Carolina Soriano; Alison M Ayres; Kristin Schwab; Joanna Pera; Andrzej Urbanik; Natalia S Rost; Joshua N Goldstein; Anand Viswanathan; Alexander Pichler; Christian Enzinger; Bo Norrving; David L Tirschwell; Magdy Selim; Devin L Brown; Scott L Silliman; Bradford B Worrall; James F Meschia; Chelsea S Kidwell; Joan Montaner; Israel Fernandez-Cadenas; Pilar Delgado; Joseph P Broderick; Steven M Greenberg; Jaume Roquer; Arne Lindgren; Agnieszka Slowik; Reinhold Schmidt; Matthew L Flaherty; Dawn O Kleindorfer; Carl D Langefeld; Daniel Woo; Jonathan Rosand
Journal:  Stroke       Date:  2012-08-28       Impact factor: 7.914

Review 6.  Gut microbiota in hypertension.

Authors:  Pedro A Jose; Dominic Raj
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-09       Impact factor: 2.894

Review 7.  Progress and future aspects in genetics of human hypertension.

Authors:  Qi Zhao; Tanika N Kelly; Changwei Li; Jiang He
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

8.  Effectiveness of a web-based protocol for the screening and phenotyping of individuals with Tourette syndrome for genetic studies.

Authors:  Crystelle A Egan; Susan E Marakovitz; Julia A O'Rourke; Lisa Osiecki; Cornelia Illmann; Lauren Barton; Elizabeth McLaughlin; Rachel Proujansky; Justin Royal; Heather Cowley; Martha Rangel-Lugo; David L Pauls; Jeremiah M Scharf; Carol A Mathews
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-10-22       Impact factor: 3.568

9.  Genetic heterogeneity of Alzheimer's disease in subjects with and without hypertension.

Authors:  Alireza Nazarian; Konstantin G Arbeev; Arseniy P Yashkin; Alexander M Kulminski
Journal:  Geroscience       Date:  2019-05-05       Impact factor: 7.713

10.  A common hypofunctional genetic variant of GPER is associated with increased blood pressure in women.

Authors:  Ross D Feldman; Robert Gros; Qingming Ding; Yasin Hussain; Matthew R Ban; Adam D McIntyre; Robert A Hegele
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.